BROADWOOD PARTNERS, L.P.
CIK 1278386 · last filed 2026-04-20
BROADWOOD PARTNERS, L.P. is a corporate insider who has filed 67 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider bought $2.0M of OCX on Apr 20, 2026. Across all open-market trades the lifetime net is −$179.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $982.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$982.67M
8
67
-$179.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 24,148,020 | $3.20 | $77.27M | $137.03M | 12 | 2026-04-20 |
| STAA | 10%+ Owner | 30,907,258 | $28.37 | $876.84M | -$233.92M | 30 | 2026-01-13 |
| LCTX | Director | 83,332,510 | $1.27 | $105.83M | $21.00M | 1 | 2024-02-08 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 10,584,312 | — | — | $12.42M | 1 | 2017-10-18 | |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 30,034,469 | — | — | $22.26M | 4 | 2017-10-17 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 5,283,320 | — | — | -$149.77M | 3 | 2014-02-13 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,510,046 | — | — | $8.00M | 2 | 2012-05-31 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 2,655,910 | — | — | $3.91M | 12 | 2008-01-22 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +548,583 | $1.96M | EDGAR |
| 2026-01-13 | STAA | Buy (P) | +82,455 | $1.82M | EDGAR |
| 2025-11-21 | STAA | Buy (P) | +4,500,000 | $123.18M | EDGAR |
| 2025-03-28 | STAA | Buy (P) | +340,152 | $5.95M | EDGAR |
| 2025-03-25 | STAA | Buy (P) | +410,088 | $7.24M | EDGAR |
| 2025-03-06 | STAA | Buy (P) | +83,859 | $1.45M | EDGAR |
| 2025-02-10 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +15,497,085 | $31.77M | EDGAR |
| 2025-01-16 | STAA | Buy (P) | +88,128 | $1.89M | EDGAR |
| 2024-12-18 | STAA | Buy (P) | +240,600 | $5.84M | EDGAR |
| 2024-10-04 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +3,946,017 | $11.63M | EDGAR |